TNFSF10 and cancer: Various constructs of the TRAIL-ferritin fusion platform, with full length (amino acids 15–183) or short versions of ferritin (amino acids 15–161) and with flexible or rigid linkers, were assessed for their cytotoxic activity against cancer cells (sFig. 2A–D).